footnote_entry
TL3 Regular · Augsburg, DE
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 10 January 2025 · last posted 3d · groups: pharmacists
130 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #91 · Lounge › Introductions · 25 Jul 2026 · 14 likes This follows post #88 rather than contradicting it. Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce…
-
What a certificate commits its issuer to Replied, post #101 · Analytics › COA interpretation · 25 Jul 2026 · 22 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Signs of dehydration worth acting on Replied, post #37 · Safety › Adverse events · 24 Jul 2026 · 0 likes Coming back to post #35, because the follow-up matters more than the original answer. Medullary thyroid carcinoma is the reason these compounds are contraindicated in…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #145 · Sourcing › Logistics · 24 Jul 2026 · 7 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Research-use-only status: what it means legally and practically Replied, post #80 · Compounds › Other compounds · 23 Jul 2026 · 5 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #55 · Access › Insurance & coverage · 22 Jul 2026 · 17 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #127 · Evidence › Journal club · 21 Jul 2026 · 0 likes post #126 is right about the mechanism and I think understates the practical bit. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #40 · Practice › Interactions · 18 Jul 2026 · 11 likes Coming back to post #38, because the follow-up matters more than the original answer. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
-
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #8 · Practice › Administration · 18 Jul 2026 · 1 like Picking up post #5: that is the part I would want checked first. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles.…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #48 · Research Methods › Statistics · 18 Jul 2026 · 0 likes Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #42 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Insurance and replacement policies, compared Replied, post #93 · Sourcing › Logistics · 16 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #95 · Analytics › Home & field testing · 15 Jul 2026 · 30 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #44 · Evidence › Trials · 12 Jul 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #29 · Compounds › Retatrutide · 10 Jul 2026 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Prescription portability between countries Replied, post #89 · Access › International · 6 Jul 2026 · 7 likes On post #85 — agreed on the reasoning, with one qualification. Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is…
-
The anatomy of a question that gets answered within an hour Replied, post #93 · Start Here › How to Ask · 28 Jun 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #85 · Data & Tools › Datasets · 24 Jun 2026 · 3 likes post #84 is right about the mechanism and I think understates the practical bit. How to contribute: if you have longitudinal data you want to add, the format is simple:…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #84 · Evidence › Preprints · 20 Jun 2026 · 2 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Fasting versus non-fasting and which tests care Replied, post #50 · Clinical › Bloodwork · 17 Jun 2026 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
What I would want from a home test that does not exist yet Replied, post #12 · Analytics › Home & field testing · 16 Jun 2026 · 13 likes Coming back to post #10, because the follow-up matters more than the original answer. False positives and false negatives: no test has 100% sensitivity and 100%…
-
Pooling trials with different estimands Replied, post #25 · Evidence › Meta-analyses · 14 Jun 2026 · 5 likes post #24 is right about the mechanism and I think understates the practical bit. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #27 · Practice › Reconstitution · 14 Jun 2026 · 13 likes Picking up post #24: that is the part I would want checked first. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL…
-
Designing a personal experiment that could change your mind — one year on Replied, post #59 · Research Methods › N-of-1 designs · 12 Jun 2026 · 1 like Picking up post #56: that is the part I would want checked first. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #24 · Compounds › Tirzepatide · 8 Jun 2026 · 22 likes Picking up post #21: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Request: a per-category review queue Replied, post #8 · Meta › Feature requests · 28 May 2026 · 2 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Injection volume, overload, and peak distortion Replied, post #21 · Analytics › HPLC & UHPLC · 26 May 2026 · 3 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
The "under review" status pill and when a moderator applies it Replied, post #115 · Evidence › Preprints · 5 May 2026 · 4 likes This follows post #112 rather than contradicting it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled…
-
A single out-of-range value on an otherwise normal panel Replied, post #42 · Clinical › Bloodwork · 4 May 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Request: show the solution author in the topic list — what changed since Replied, post #35 · Meta › Feature requests · 2 May 2026 · 1 like post #34 answers the question as asked. The question underneath it is different. Tracking: staff will update the status of feature requests (under consideration,…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #49 · Start Here › Welcome · 30 Apr 2026 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
List price versus negotiated price versus what you pay Replied, post #108 · Access › Pricing · 17 Apr 2026 · 0 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #73 · Evidence › Trials · 17 Apr 2026 · 0 likes Worth separating two things that post #69 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Sample handling between despatch and injection Replied, post #43 · Analytics › Method validation · 16 Apr 2026 · 31 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Journal club: LEADER as the historical anchor Replied, post #60 · Evidence › Journal club · 14 Apr 2026 · 1 like On post #56 — agreed on the reasoning, with one qualification. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #21 · Practice › Administration · 2 Apr 2026 · 5 likes On post #17 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #76 · Practice › Interactions · 28 Mar 2026 · 0 likes post #75 is right about the mechanism and I think understates the practical bit. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #15 · Evidence › Journal club · 26 Mar 2026 · 14 likes This follows post #12 rather than contradicting it. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological…
-
[2026 update] What a purity-only report leaves out Replied, post #63 · Sourcing › Independent verification · 23 Mar 2026 · 23 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #69 · Practice › Reconstitution · 20 Mar 2026 · 4 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #77 · Practice › Storage & stability · 7 Mar 2026 · 20 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #45 · Sourcing › Logistics · 25 Feb 2026 · 0 likes post #44 is right about the mechanism and I think understates the practical bit. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others…
-
How to ask about something you suspect is a bad idea Replied, post #55 · Start Here › How to Ask · 15 Feb 2026 · 0 likes Picking up post #52: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #38 · Outcomes › Progress reports · 11 Feb 2026 · 20 likes post #37 is right about the mechanism and I think understates the practical bit. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #32 · Practice › Interactions · 8 Jan 2026 · 1 like post #31 is right about the mechanism and I think understates the practical bit. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Preprint servers and what screening they do Replied, post #15 · Evidence › Preprints · 4 Jan 2026 · 9 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #65 · Practice › Side effects · 28 Dec 2025 · 1 like Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Why "add 2 mL" is not an instruction Replied, post #20 · Practice › Reconstitution · 22 Dec 2025 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The headache that turns out to be dehydration Replied, post #97 · Nutrition & Training › Hydration & electrolytes · 16 Dec 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #11 · Sourcing › Red flags · 10 Dec 2025 · 22 likes Picking up post #8: that is the part I would want checked first. Pricing patterns: unusually low prices for what are otherwise consistent with market rates might…
-
Robustness: the parameters worth deliberately varying Replied, post #53 · Analytics › Method validation · 9 Dec 2025 · 0 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #39 · Sourcing › Regulatory · 9 Dec 2025 · 2 likes This follows post #36 rather than contradicting it. Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for…
-
Tracking a preprint to publication: a worked example Replied, post #62 · Evidence › Preprints · 6 Dec 2025 · 8 likes post #61 is right about the mechanism and I think understates the practical bit. Peer review as a filter: published papers have survived a review process that rejects…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg Started this topic · Compounds › Semaglutide · 29 Nov 2025 · 10 likes What the published dose-response for semaglutide actually looks like above 2.4 mg — that is the question, and I have not found it answered plainly anywhere I have…
-
Angle of injection and whether 90 degrees is always right Replied, post #55 · Practice › Administration · 24 Nov 2025 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #30 · Documentation › Doc review · 14 Nov 2025 · 0 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Documentation that materially improves an appeal's chances Replied, post #55 · Access › Insurance & coverage · 7 Nov 2025 · 26 likes Picking up post #52: that is the part I would want checked first. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run…
-
What a purity-only report leaves out Replied, post #76 · Sourcing › Independent verification · 6 Nov 2025 · 9 likes post #75 answers the question as asked. The question underneath it is different. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
EMA product information as a primary source Replied, post #37 · Regional › European Union · 6 Nov 2025 · 21 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #91 · Safety › Adverse events · 4 Nov 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Research-use-only labelling: what it means and what it does not Replied, post #54 · Sourcing › Regulatory · 3 Nov 2025 · 8 likes post #53 answers the question as asked. The question underneath it is different. Approval versus licensing: a compound can be approved for a specific indication in one…
-
A 40-week log with the measurement method stated Replied, post #88 · Outcomes › Progress reports · 28 Oct 2025 · 12 likes Worth separating two things that post #84 runs together. Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight…
-
Documentation that appears only after payment Replied, post #60 · Sourcing › Red flags · 27 Oct 2025 · 7 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Revisiting: German, French and Dutch differences, compared Replied, post #92 · Regional › European Union · 25 Oct 2025 · 10 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #121 · Lounge › Off topic · 25 Oct 2025 · 0 likes I read post #119 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Specification in the result column: why that is a meaningful error Replied, post #63 · Analytics › COA interpretation · 25 Oct 2025 · 2 likes post #62 answers the question as asked. The question underneath it is different. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the…
-
A 40-week log with the measurement method stated Replied, post #63 · Outcomes › Progress reports · 24 Oct 2025 · 0 likes Picking up post #60: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #56 · Analytics › COA interpretation · 14 Oct 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Persistent vomiting and the threshold for seeking help Replied, post #50 · Safety › Adverse events · 14 Oct 2025 · 0 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #78 · Practice › Storage & stability · 11 Oct 2025 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #7 · Practice › Storage & stability · 2 Oct 2025 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 0 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
What I would record differently if I started again — the long version Replied, post #11 · Outcomes › Progress reports · 26 Sep 2025 · 29 likes post #10 is right about the mechanism and I think understates the practical bit. Protein intake and resistance training: both self-reported and therefore optimistic in…
-
Managing an unplanned gap in supply — what changed since Replied, post #62 · Access › Shortages · 14 Sep 2025 · 0 likes On post #58 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Thyroid function tests during substantial weight change Replied, post #54 · Clinical › Bloodwork · 7 Sep 2025 · 20 likes post #53 answers the question as asked. The question underneath it is different. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
-
Mood changes: monitoring, and when to involve a professional — what changed since Started this topic · Wellbeing › Mental health · 4 Sep 2025 · 51 likes Mood changes: monitoring, and when to involve a professional — what changed since Writing it up because I had to work it out twice and would rather nobody else did.…
-
Canadian access and provincial variation — one year on Replied, post #44 · Regional › North America · 29 Jul 2025 · 10 likes Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #33 · Practice › Dosing & titration · 21 Jul 2025 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 3 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
A field-by-field walk through a certificate of analysis Replied, post #15 · Analytics › COA interpretation · 14 Jul 2025 · 14 likes I read post #13 twice before replying, because I had assumed the opposite. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent…
-
What this community means by "a source", in practical terms Replied, post #33 · Start Here › Welcome · 13 Jul 2025 · 1 like On post #29 — agreed on the reasoning, with one qualification. On the reading order question specifically: start with the how-to-ask materials in this category, then…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #24 · Compounds › Secretagogues & GH axis · 12 Jul 2025 · 4 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Critiquing an observational claim about a class effect — one year on Started this topic · Evidence › Study critique · 29 Jun 2025 · 33 likes Critiquing an observational claim about a class effect — one year on — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #156 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 0 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #65 · Sourcing › Independent verification · 19 Jun 2025 · 22 likes I read post #63 twice before replying, because I had assumed the opposite. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #66 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 0 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #51 · Compounds › Retatrutide · 16 May 2025 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #35 · Outcomes › Body composition · 13 May 2025 · 22 likes I read post #33 twice before replying, because I had assumed the opposite. Precision versus accuracy: the precision you need depends on what question you are answering.…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #5 · Regional › European Union · 12 May 2025 · 21 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Follow-up: What other technical communities get right that we do not Replied, post #90 · Lounge › Off topic · 7 May 2025 · 1 like This follows post #87 rather than contradicting it. Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #45 · Data & Tools › Calculators · 2 May 2025 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #28 · Clinical › Comorbidities · 28 Apr 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Follow-up: Requesting a page: what makes a good request Replied, post #24 · Documentation › Wiki requests · 21 Apr 2025 · 9 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Retatrutide dose escalation in the published trials Replied, post #132 · Compounds › Retatrutide · 14 Apr 2025 · 0 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #51 · Compounds › Tirzepatide · 1 Apr 2025 · 15 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
An orphaned page with no inbound links Replied, post #21 · Meta › Wiki maintenance · 25 Mar 2025 · 5 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the maintainer.
-
Follow-up: Requesting a page: what makes a good request Replied, post #11 · Documentation › Wiki requests · 17 Mar 2025 · 0 likes Worth separating two things that post #7 runs together. Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example,…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #4 · Compounds › Retatrutide · 15 Mar 2025 · 20 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #4 · Sourcing › Independent verification · 15 Mar 2025 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #14 · Sourcing › Vendor reports · 15 Mar 2025 · 0 likes Worth separating two things that post #10 runs together. Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is…
-
Fibre intake when total intake falls, and the constipation link Replied, post #38 · Nutrition & Training › Protein & intake · 10 Mar 2025 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #25 · Pharmacology › Receptor biology · 1 Mar 2025 · 0 likes Picking up post #22: that is the part I would want checked first. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #115 · Compounds › Semaglutide · 25 Feb 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #18 · Clinical › Comorbidities · 20 Feb 2025 · 25 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #24 · Compounds › Tirzepatide · 19 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Validating a method you did not develop — does this still hold? Replied, post #5 · Analytics › Method validation · 12 Feb 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Transfer between laboratories: a method can be transferred from one lab to another, but the…
-
How compounding permissions changed when supply normalised Replied, post #14 · Sourcing › Regulatory · 31 Jan 2025 · 6 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #41 · Compounds › Semaglutide · 27 Jan 2025 · 4 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Ipamorelin selectivity claims and where they came from Replied, post #8 · Compounds › Secretagogues & GH axis · 22 Jan 2025 · 0 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 10 Jan 2025 · 13 likes post #7 is right about the mechanism and I think understates the practical bit. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
What changed in 2026, by region Replied, post #47 · Access › International · 29 Dec 2024 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #133 · Clinical › Prescriber conversations · 28 Dec 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #64 · Evidence › Journal club · 18 Dec 2024 · 30 likes This follows post #61 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
A promotion I argued against, and why I lost Replied, post #23 · Documentation › Doc review · 7 Dec 2024 · 7 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #26 · Nutrition & Training › Protein & intake · 28 Nov 2024 · 11 likes On post #22 — agreed on the reasoning, with one qualification. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #30 · Practice › Interactions · 25 Nov 2024 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #67 · Devices › Syringes & needles · 17 Nov 2024 · 7 likes Worth separating two things that post #63 runs together. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #28 · Evidence › Journal club · 9 Nov 2024 · 24 likes This follows post #25 rather than contradicting it. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #9 · Compounds › Oral incretins · 5 Nov 2024 · 7 likes Worth separating two things that post #5 runs together. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #56 · Devices › Syringes & needles · 28 Oct 2024 · 0 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Converting between mg/mL and units per dose, both directions Replied, post #60 · Practice › Reconstitution · 22 Oct 2024 · 2 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #7 · Evidence › Journal club · 11 Oct 2024 · 3 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #61 · Evidence › Journal club · 2 Oct 2024 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Taste changes and food aversion, reported and discussed Replied, post #19 · Practice › Side effects · 14 Sep 2024 · 5 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Signs of dehydration worth acting on Replied, post #9 · Safety › Adverse events · 26 Aug 2024 · 11 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #62 · Compounds › Retatrutide · 20 Jul 2024 · 0 likes This follows post #59 rather than contradicting it. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #33 · Practice › Interactions · 12 Jul 2024 · 0 likes Coming back to post #31, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
-
Cold packs, phase-change material, and what survives ten days Replied, post #57 · Sourcing › Logistics · 30 Jun 2024 · 1 like Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Cold packs, phase-change material, and what survives ten days Replied, post #10 · Sourcing › Logistics · 12 Jun 2024 · 18 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
The mass-error checker and its intended scope Replied, post #33 · Data & Tools › Calculators · 6 Jun 2024 · 11 likes post #32 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…